Month: January 2024

Extendicare Announces January 2024 Dividend of C$0.04 per Share

Written by Customer Service on January 15, 2024. Posted in Dividend Reports And Estimates.

MARKHAM, Ontario, Jan. 15, 2024 (GLOBE NEWSWIRE) — Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common Share”) for the month of January 2024, which is payable on February 15, 2024 to shareholders of record at the close of business on January 31, 2024. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). About Extendicare Extendicare is a leading provider of care and services for seniors across Canada, operating under the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. We are committed to delivering quality care throughout the health continuum to meet the needs of a growing seniors population. We operate or provide managed services...

Corporate Wellness Market Size Worth USD 81.19 Billion in 2032 | Emergen Research

Written by Customer Service on January 15, 2024. Posted in Mergers And Acquisitions.

Increasing prevalence of chronic diseases, reduction in employee healthcare costs, and rising number of deskbound job profiles are key factors driving corporate wellness market revenue growth. Vancouver, Jan. 15, 2024 (GLOBE NEWSWIRE) — The global corporate wellness market size was USD 53.04 Billion in 2022 and is expected to register a rapid revenue CAGR of 4.3% during the forecast period. Increasing prevalence of chronic diseases, reduction in employee healthcare costs, and rising number of deskbound job profiles are key factors driving market revenue growth. Corporate wellness initiatives encompass a range of policies, programs, and benefits to tackle various health risks and conditions, impacting both employees and organization. According to National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), in the...

Aptamers Market Size Worth USD 13.5 Billion in 2032 | Emergen Research

Written by Customer Service on January 15, 2024. Posted in Mergers And Acquisitions.

Increasing investments in aptamer Research & Development (R&D) and rapid technological advancements in aptamers are key factors driving aptamers market revenue growth. Vancouver, Jan. 15, 2024 (GLOBE NEWSWIRE) — The global aptamers market size was USD 1.80 Billion in 2022 and is expected to register a rapid revenue CAGR of 24.22% during the forecast period. Increasing investments in aptamer Research & Development (R&D) and rapid technological advancements in aptamers are key factors driving market revenue growth. Increasing prevalence of chronic disease is another key factor driving revenue growth of the market. World Health Organization (WHO) estimated that 71% individuals died globally due to chronic disease. Over 7 out of 10 deaths are caused by chronic diseases, such as heart disease, stroke, cancer, diabetes,...

High Throughput Screening Market Size Worth USD 33.20 Billion in 2032 | Emergen Research

Written by Customer Service on January 15, 2024. Posted in Mergers And Acquisitions.

Rising need for diverse compound libraries are major factors driving High Throughput Screening market revenue growth. Vancouver, Jan. 15, 2024 (GLOBE NEWSWIRE) — The global high throughput screening market size was USD 23.20 Billion in 2022 and is expected to register a revenue CAGR of 3.2% during the forecast period. Increasing funding for Research & Development (R&D), regulatory support for innovative approaches, and rising need for diverse compound libraries are major factors driving market revenue growth. The advancements in automation and robotics, focus on personalized medicine, and efficiency in drug discovery are among other key factors contributing to market revenue growth. Automated systems are streamlining the screening process, enabling rapid and efficient analysis of large compound libraries, thus significantly...

Medical Holography Market Size Worth USD 41.94 Billion in 2032 | Emergen Research

Written by Customer Service on January 15, 2024. Posted in Mergers And Acquisitions.

Increasing investments in enhanced surgical planning and training and patient education and communication is a key factor driving Medical Holography market revenue growth. Vancouver, Jan. 15, 2024 (GLOBE NEWSWIRE) — The global medical holography market size was USD 3.40 Billion in 2022 and is expected to register a rapid revenue CAGR of 28.6% during the forecast period. Increasing investments in enhanced surgical planning and training and patient education and communication is a key factor driving market revenue growth. Healthcare institutions recognize the transformative potential of holography in revolutionizing surgical procedures. The ability to stimulate surgeries in a realistic Three Dimensional (3D) environment allows surgeons to refine their skills and plan complex procedures with precision. As a result, there is an increasing...

Flagship Communities Real Estate Investment Trust Announces January 2024 Cash Distribution

Written by Customer Service on January 15, 2024. Posted in Dividend Reports And Estimates.

Not for distribution to U.S. newswire services or dissemination in the United States. TORONTO, Jan. 15, 2024 (GLOBE NEWSWIRE) — Flagship Communities Real Estate Investment Trust (the “REIT”) (TSX:MHC.U; MHC.UN) announced today a cash distribution of US$0.0492 per REIT unit for the month of January 2024, representing US$0.59 per REIT unit on an annual basis. Payment will be made on or about February 15, 2024 to unitholders of record as of the close of business on January 31, 2024. Distributions paid to Canadian unitholders (and other non-U.S. unitholders) generally will be subject to U.S. withholding tax. Unitholders should consult their own tax advisors for advice with respect to the tax consequences of receiving a distribution from the REIT in their own circumstances. About Flagship Communities Real Estate Investment Trust Flagship...

TRX Gold Reports First Quarter 2024 Results

Written by Customer Service on January 15, 2024. Posted in Earnings Releases And Operating Results.

Mill Expansion Advances to Increase Gold ProductionFigure 1:1,000+ tpd Processing Plant at Buckreef Gold Mine, showing new CIL tanks and conveyor feed to the new ball mills (Q1 2024)Figure 2:Buckreef Gold Tailings Storage Facility Expansion at TSF 2.2 (Q1 2024 – first lift completed and TSF is now operational)Figure 3:Buckreef Gold’s new and expanded crushing circuit under construction (Q1 2024)Figure 4:Buckreef Gold’s new cone crusher and site construction underway (Q1 2024)Figure 5:Buckreef Gold’s new jaw crusher and site construction underway (Q1 2024)TORONTO, Jan. 15, 2024 (GLOBE NEWSWIRE) — TRX Gold Corporation (TSX: TNX) (NYSE American: TRX) (the “Company” or “TRX Gold”) today reported its results for the first quarter of 2024 (“Q1 2024”) for the three months ended November...

Alamos Gold Announces Acquisition of Orford Mining Including the Qiqavik Gold Project

Written by Customer Service on January 15, 2024. Posted in Mergers And Acquisitions.

Figure 1 _ Orford Mining Project LocationsFigure 1 _ Orford Mining Project LocationsTORONTO, Jan. 15, 2024 (GLOBE NEWSWIRE) — Alamos Gold Inc. (TSX:AGI; NYSE:AGI) (“Alamos” or the “Company”) is pleased to announce that it has entered into a definitive agreement (the “Agreement”) pursuant to which Alamos will acquire all of the issued and outstanding shares of Orford Mining Corporation (TSXV:ORM) (“Orford”) by way of a court-approved plan of arrangement (the “Transaction”). The acquisition will consolidate Alamos’ existing ownership of Orford shares through which the Company will add the highly prospective Qiqavik Gold Project, located in Quebec, Canada. Alamos will also be acquiring interests in several exploration stage critical mineral and gold projects in Quebec, including West Raglan, the Joutel Properties, and Nunavik...

NH TherAguix appoints Jean-Philippe DEL as Chief Financial Officier

Written by Customer Service on January 15, 2024. Posted in Public Companies.

PRESS RELEASE NH TherAguix appoints Jean-Philippe Del as Chief Financial Officer. Paris, January 15th, 2024 – NH TherAguix SA (“NHT”), a Phase II clinical stage biotech company developing AGuIX®, a nanodrug to treat radiotherapy eligible tumours and metastases across oncology indications, today announced the appointment of Jean-Philippe Del as Chief Financial Officer (CFO). Jean-Philippe Del brings more than 18-year experience in the biotechnology industry from Transgene (Euronext Paris) where he last was CFO. In this position, Jean-Philippe led multiple successful transactions with €150 million raised in capital markets and non-dilutive funding. He also supported Transgene’s operations by leading all aspects of the financial strategy, management and operations. Prior to Transgene, Jean-Philippe was Financial Auditor at Mazars and Kronenbourg...

cBrain beats expectations on top and bottom lines as subscription revenue jumps

Written by Customer Service on January 15, 2024. Posted in Dividend Reports And Estimates.

Company Announcement no. 01/2024 cBrain beats expectations on top and bottom lines as subscription revenue jumpsCopenhagen, January 15, 2024cBrain (NASDAQ: CBRAIN) is pleased to recognize a significant jump in subscription revenue during the fourth quarter of 2023 due to increased usage of the F2 digital platform across the user base. Consequently, cBrain now upgrades total revenue growth guidance to 25-27%, up from previous 20-25%, and upgrades earnings before tax (EBT) guidance to 32-34%, up from previous 20-25%. — For the fiscal year 2023, cBrain initially guided revenue growth of 15-20% and earnings before tax (EBT) of 18-22%. First half year 2023 results exceeded expectations due to increased software sales. Consequently, in July the full-year revenue growth guidance for 2023 was increased to 20-25%, up from the previous range...

Month: January 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals